Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Equity Ratio (2016 - 2026)

Amphastar Pharmaceuticals has reported Equity Ratio over the past 13 years, most recently at 0.48 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 4.29% year-over-year to 0.48; the TTM value through Dec 2025 reached 0.48, up 4.29%, while the annual FY2025 figure was 0.48, 4.29% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.48 at Amphastar Pharmaceuticals, up from 0.47 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.71 in Q4 2022 and troughed at 0.39 in Q3 2023.
  • A 5-year average of 0.56 and a median of 0.48 in 2025 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: tumbled 44.57% in 2023 and later grew 22.23% in 2024.
  • Year by year, Equity Ratio stood at 0.66 in 2021, then increased by 7.39% to 0.71 in 2022, then tumbled by 40.68% to 0.42 in 2023, then rose by 9.84% to 0.46 in 2024, then rose by 4.29% to 0.48 in 2025.
  • Business Quant data shows Equity Ratio for AMPH at 0.48 in Q4 2025, 0.47 in Q3 2025, and 0.47 in Q2 2025.